But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ageing Restasis potentially facing generic competition, there’s a lot to play for ...

Be aware that treatments such as Restasis may take up to six months to work and can cause burning and discomfort. Likewise, Xiidra takes around three months to alleviate symptoms, with many ...

and that delay could allow competitors seeking to eat into a market for chronic dry eye disease currently dominated by Xiidra and AbbVie's Restasis (cyclosporine). Sales of the two drugs were $334 ...

Restasis (cyclosporine) is a brand-name drug that’s prescribed for chronic dry eye in adults and certain children. Restasis comes as an eye drop solution. The typical dosage is one drop per ...